Comparison of Combined/Carvedilol Moderate Dose Atorvastatin to Single High Dose Atorvastatin for the Prevention of Contrast-Induced Nephropathy after Cardiac Catheterization - Egyptian Knowledge Bank - troweb

135782

Comparison of Combined/Carvedilol Moderate Dose Atorvastatin to Single High Dose Atorvastatin for the Prevention of Contrast-Induced Nephropathy after Cardiac Catheterization

Article

Last updated: 22 Jan 2023

Overview Similar Items

Article

High dose of Atorvastatin versus Rosuvastatin as Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention

Article

THE EFFECT OF ADMINISTRATION OF ASCORBIC ACID IN PREVENTION OF CONTRAST INDUCED NEPHROPATHY IN PATIENTS WITH RENAL IMPAIRMENT UNDERGOING CORONARY INTERVENTION

Article

The Effect of SGLT2 Inhibitors on the Development of Contrast-Induced Nephropathy in Diabetic Patients with Non-ST Segment Elevation Myocardial Infarction

Article

EFFECTS OF ROSUVASTATIN IN EXPERIMENTALLY-INDUCED CARDIAC ISCHEMIA AND ON AORTIC VASCULAR REACTIVITY.

Article

Synergistic reduction by metformin and atorvastatin combination of hepato-metabolic changes in rat model of metabolic syndrome

Article

Risk Factors of Contrast-Induced Nephropathy after Percutaneous Coronary Interventions: An Observational Study

Article

COMPARSION BETWEEN RENOPROTECTIVE EFFECTS OF CARVEDILOL AND LISINOPRIL IN L-NAME-TREATED RATS

Article

Carvedilol and rosuvastatin mitigate nephrotoxicity of sodium valproate through activation of Nrf2 pathway in rats.

Article

CHADS2-VASC Score as a Predictor for Contrast Induced Nephropathy in Patient with Acute Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention

Thesis

Iso-osmolar versus low-osmolar contrast media in reducing contrast induced nephropathy in patient with renal impairment undergoing coronary angiography or intervention